Large scale ICU data sharing for 1000 critically ill patients with severe acute ARDS corona virus 2 “SARS” covid 19 in three distinct centers.

Document Type : Original Article

Authors

1 Anaesthesia and intensive care, faculty of medicine,minia university

2 Anesthesia and intensive care department,minia university,minia university hospital, minia ,egypt

3 Anesthesia

Abstract

Background:A coronavirus disease pandemic (COVID-19) caused by the SARS-CoV-2 coronavirus has been spreading to China since December 2019 and is now regarded as a global threat. The infection has an average incubation period of 5.2 days and causes fever, coughing, and other flu-like symptoms. Objectives:The statistical analysis included a large group of critically ill patients with severe acute ARDS corona virus 2 "SARS" COVID 19.

Study design:Three different health institutions in the MINYA governorate were used to gather data on 1000 people who had their COVID-19 tested in a lab. 

Methods:All patients who had a positive polymerase chain reaction (PCR) test result on a nasopharyngeal sample and had a verified case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection were included. When patients were admitted to MINYA health acute care hospitals, clinical outcomes were monitored.

Results:The results showed that 694 patients (69.7%) did not have acute renal impairment whereas 301 individuals (30.3%) did. Additionally, stage I was seen in 155 (51.5%) patients, stage II in 69 (21.9%), and stage III in 77 (25.6%) people, according to the KDIGO classification.

Conclusion:Despite the fact that acute renal injury is a common finding in COVID-19 patients, the risk of death is increased in these people. Furthermore, a statistically significant relationship existed between AKI and (Age, DM, CKD, HTN, Non-invasive MV, Invasive MV, Death, O2 saturation on admission, p/f ratio on admission, and Creatinine).

Keywords

Main Subjects